“Online marketing increasingly effective for pharma PMLiVE The Eighth Annual Online Marketing Effectiveness Benchmarks for the Pharmaceutical Industry report published by comScore Health Solutions demonstrated that pharma online advertising has the...”
Keeping mentally busy tied to less memory loss 5 : 00PM GMA News They had each taken an average of six annual cognitive tests during the study, which showed that 102 developed dementia and 51 developed mild cognitive impairment.
It’s one of those thoughts many mHealth insiders and observers have at some point had: What if one could put the power of Watson analytics into a smartphone and interact with it like Apple’s Siri at the point of care?
Well, that specific dream moved closer to reality on Tuesday when Apple and IBM joined forces to create a mobile platform christened IBM Mobile First for iOS.
“For the first time ever we’re putting IBM’s renowned big data analytics at iOS users’ fingertips,” Apple CEO Tim Cook said in a prepared statement. “This is a radical step for enterprise and something that only Apple and IBM can deliver.”
IBM CEO Ginni Rometty added that the intention is to bring the same “innovations [that] have transformed our lives,” into the ways that people work, thereby “allowing people to re-imagine work, industries, and professions.”
To that end, the companies hope that IBM Mobile First for iOS will “transform enterprise mobility through a new class of business apps,” they explained.
It’s not all that often technology giants align and rattle off healthcare as one of their target verticals, much less that Apple joins forces with any of the IT old guard — which gives the partnership a booster shot of luster. And in an mHealth industry currently going like gangbusters with too many startups to count, the sheer scale that Apple and IBM bring at the very least has the potential for significant market-shaping.
Although nanomedicine is a promising area of research, scientists have been unable to figure out a way to deliver drugs using nanoparticles other than by injection, which is both distasteful and inconvenient for patients. Now, a team of researchers from MIT and Brigham and Women's Hospital (BWH) have developed a new nanoparticle that can be absorbed through the digestive tract, allowing patients to take a pill instead of receiving injections.
"If you were a patient and you had a choice, there's just no question," Professor Robert Langer, of MIT's Koch Institute for Integrative Cancer Research, stated in a press release. “Patients would always prefer drugs they can take orally.”
Ultrafine particles, or nanoparticles, are between one and 100 nanometers in size. What makes nanoparticles so interesting to scientists, particularly in the field of medicine, is the fact that the physics underlying nanoparticles means that their properties are different from the properties of the bulk material. Additionally, size and surface characteristics of nanoparticles can be manipulated. Yet, nanoparticles have not yet been available as a pill because, despite their tiny size, they are unable to penetrate the intestinal lining. This is no simple feat as the lining is made of a layer of epithelial cells that join together forming impenetrable barriers known as tight junctions. more at : http://healthworkscollective.com/susan-scutti/140111/nanoparticle-pills-usher-medicine-future-no-more-needles
MEDICAL Airway muscle-on-a-chip to aid in search for new asthma treatments By Darren Quick September 24, 2014 3 Pictures A human airway muscle-on-a-chip developed at Harvard's Wyss Institute could hel...
Your smartphone is not only your best friend, it's also become your personal trainer, coach, medical lab and maybe even… (RT @carloscomsalud: El móvil ya puede dar servicios que antes solo lograba un centro de salud
The use of electronic health records to identify the best treatment option for patients is more efficient and less costly than the current clinical trial process, according to a study published in the journal Health Technology Assessment
For the study, which was funded in part by the National Institute for Health Research and the Welcome Trust, researchers from several universities in the United Kingdom, used a new computer program in 23 approved general practitioners across England and Scotland.
The first part of the study used 300 patients' electronic health records, which are stored in the Clinical Practice Research Datalink and updated during routine medical visits, to monitor the effects of their prescribed treatments.
A second part of the study, which involved 31 participants, looked at the use of antibiotics among patients with chronic obstructive pulmonary disease.
The researchers determined that they were able to understand health patterns related to specific prescribed medications and determine which treatments were more effective by analyzing EHRs.
They added that the EHR analysis offers a larger and more diverse overview of the general population than current clinical trial methods.
The researchers also noted that using EHRs allows the analysis to be conducted with minimal effects on the lives of the patients, whose involvement in the process stops after their initial consent.
According to the researchers, 26 out of 27 general practitioners who participated in the study expressed strong support for the use of patients' EHRs for research purposes. In addition, 10 patients who were interviewed by the researchers all said that their involvement in trial was an acceptable practice
The field of medical technology is incredibly exciting these days. Each breakthrough has the potential to impact the lives of thousands of patients, sometimes changing the course of medical history and forever improving the human experience. Such can be argued for antibiotics, x-rays, vaccines, or even things as seemingly simple as disposable medical instruments (an extremely important sanitary innovation). Year after year, teams of research physicians and engineers work to advance our knowledge and abilities.
This article reviews some of the most influential medical innovations of the past year. From new insights in the treatment of diabetes to a new type of optical surgical procedure, incredible innovations and advancements have been achieved this year.
Implant Relieving Severe Headache Pain
A new type of neuromodulation therapy has emerged that seems to be an effective treatment for cluster and migraine headaches. Neuromodulation therapy treats a cluster of nerves behind the face that signal headache pain. This device, implanted in the face by way of the mouth, is positioned to stimulate the facial nerve that relieves headaches when stimulated. A separate device, placed on the cheek, activates the device, relieving pain in as quickly as five to ten minutes.
Bariatric Surgeries Treating Diabetes
Doctors who have performed bariatric surgery, also known as gastric bypass, have noted in the past that many of their patients had gone into diabetes remission as they recovered from surgery. This evidence has some health care professionals advocating gastric bypass treatment as an early tactic for fighting diabetes, instead of as a last-resort effort.
Bee Venom Treats HIV
One toxin found in bee venom, melittin, has been found to destroy HIV particles. Researchers claim that the particles break apart the physical structure of the virus, but are too small to have an impact on other cells within the body. A proposed method for distributing the chemical is a topical virucidal agent.
Detecting Skin Cancer with a Hand-held Device
Caught at an early stage, the survival rate for melanoma is 99 percent. In advanced stages, though, that rate drops to a mere 15 percent.
The good thing about the skin and its relation to cancer is that we can observe it. Visual detection is the best way to prevent advanced stage melanoma. Therefore checking moles and other discoloration on the skin regularly can be the best form of early detection. If a patient notices a change and brings it to the attention of their dermatologist, this new device is able to scan the area and report to the physician whether or not melanoma is present within a few seconds. It works by analyzing a database of over 10,000 images alongside a structural scan of the skin using military-grade optical technology. Clinical trials show that this device is nearly 98% effective.
Cataract Surgery at one Quadrillionth of a Second
Femtosecond laser technology will help improve the outcome in the more than 1.6 million annual cataract surgeries that are performed in the US annually. The apparatus, which separates the tissue by ablating and cleaving it, instead of cutting it, operates in one quadrillionth of a second. Its speed and precision help reduce swelling post-op, allow less time to be spent on the eye, and help the surgeon be more accurate with the implant. Optical surgeons across the globe are eager to implement this new device in order to improve their practice.